Abstract
5′-O-β-d-galactosyl-5-fluorouridine is a prodrug that can be converted by the enzyme β-d-galactosidase to the potent antineoplastic drug 5-fluorouridine. The prodrug is more than 100x less toxic than the drug to bone marrow cells in Balb/c mice. The ratio of the IC50 of the prodrug to that of the drug determined on a variety of tumor cell lines in vitro ranged from 500∶1–1000∶1. An antibody-enzyme conjugate (AEC) was synthesized and purified. Maleimide-substituted COL-1 anti-CEA monoclonal antibody was linked to free thiol groups of β-d-galactosidase. The conjugate was purified by size exclusion and ion exchange chromatography. It retained full immunoreactivity and enzyme activity. After binding to antigen-positive tumor cells, the conjugate was able to activate the prodrug and specifically kill the cells. We are continuing to investigate this model for its potential use in antibody-directed enzyme prodrug therapy (ADEPT).
Similar content being viewed by others
References
Senter, P. D., Wallace, P. M., Svensson, H. P., Vrudhula, V. M., Kerr, D. E., Hellström, I., et al. (1993)Bioconj. Chem. 4, 3.
Kuroki, M., Greiner, J. W., Simpson, J. F., Primus, F. J., Guadagni, F., and Schlom, J. (1989)Int. J. Cancer 44, 208.
Guadagni, F., Tortora, G., Roselli, M., Clair, T., Cho-Chung, Y. S., Schlom, J., et al., (1991)Int. J. Cancer 48, 413.
Craven, G. R., Steers, E., and Anfinsen, C. B. (1965)J. Biol. Chem. 240, 2468.
Tijssen, P. (1985)Practice and Theory of Enzyme Immunoassays. (van Knippenberg, P. H., and Burdon, R. H. eds.), Elsevier, Amsterdam, New York, Oxford.
Marcinkiewicz, J. and Chain, B. (1989)Immunology 68, 185.
Bosslet, K., Czech, J., Lorenz, P., Sedlacek, H. H., Schuermann, M., and Seemann, G. (1992)Br. J. Cancer 65, 234.
Benkovic, S. J. (1992)Annu. Rev. Biochem. 61, 29.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abraham, R., Aman, N., von Borstel, R. et al. Conjugates of COL-1 monoclonal antibody and β-D-galactosidase can specifically kill tumor cells by generation of 5-fluorouridine from the prodrug β-D-galactosyl-5-fluorouridine. Cell Biophysics 24, 127–133 (1994). https://doi.org/10.1007/BF02789223
Issue Date:
DOI: https://doi.org/10.1007/BF02789223